Home > PJ (current issue) > News Feature | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7269 p477
4 October 2003

This article
Reprint
Photocopy

   

PDF* 65K

News feature

An insider's view of the supplementary prescribing course for pharmacists

This week, the Robert Gordon University in Aberdeen held its first one-week residential course that forms part of its supplementary prescribing course. Clare Bellingham (on the staff of The Journal) spoke to two pharmacists on the course


Although a great number of pharmacists want to become supplementary prescribers, the number of places on the training courses is limited. Only a select group of pharmacists have made it into the first cohort. Lyn McDonald and Dr Mohamed Elfellah are two such pharmacists. Both are attending the supplementary prescribing training course at the Robert Gordon University in Aberdeen.

Lyn McDonald

Mrs McDonald is a primary care pharmacist in central Aberdeen. Her time is split between four GP surgeries. One of her roles is to support nurses by reviewing patients’ medicines before chronic disease management clinics and as part of annual care of the elderly assessments. “Recently I have found this can be quite long-winded and involves me speaking to the nurse, patient and doctor,” she comments. Becoming a supplementary prescriber will allow Mrs McDonald to review and make necessary alterations to medicines by having a consultation with the patient herself. “Initially I would like to prescribe in hypertension, but there is scope to include more chronic diseases, such as asthma, chronic obstructive pulmonary disorder and diabetes,” she says.

Dr Elfellah has worked in the cardiac unit at Aberdeen Royal Infirmary for the past eight years. “So I hope to be a supplementary prescriber in cardiology,” he says. He expects that this will also extend beyond drugs specifically for cardiac conditions to other drugs that cardiac patients might need such as laxatives or pain killers.

Mohamed Elfellah

Dr Elfellah is frustrated with the current system: “I have been writing discharge prescriptions on the cardiac ward for two years but each has to be confirmed by a doctor.” In addition, he has written, with the consultants’ approval, the hospital’s prescribing policies for various cardiac diseases such as heart failure, myocardial infarction and atrial fibrillation. His frustration is that, despite this knowledge, he has not been able to prescribe himself.

Progress so far
So after six weeks on the course, how are they getting on?

“I’ve completed the therapeutics module in hypertension,” says Mrs McDonald. “And I’ve just started the next module which is about models of consultation. This is the new thing for me as a pharmacist.” She explains: “I have done lots of patient counselling but it is always at the end of the patient’s journey. When pharmacists have prescribing rights it will mean that we are discussing the patient’s management at the beginning. This is what is so new for me so there is plenty of learning to be done.”

Mrs McDonald adds that she has found it interesting to see the different range of consulting styles that doctors have.

Ruth Edwards, lecturer in pharmacy practice, comments that a lot can be learnt from doctors: “Because it is a new role for pharmacists we have got to learn from medical models,” she comments.

Dr Derek Stewart, senior lecturer and prescribing course lead, says that the course examines communication and asks pharmacists to reflect on their own styles of consultation. Learning styles have changed, and many of the pharmacists on the course have been qualified for a number of years. This is inevitable since having experience in practice is a prerequisite to become a supplementary prescriber.

Students are encouraged to identify their own needs. Dr Stewart explains that the philosophy behind this is the Royal Pharmaceutical Society’s approach to continuing professional development — reflect, plan, record and evaluate. “Obviously this is more difficult for a learner than being told what to do,” he comments.

Part of the supplementary prescribing course is a period of learning in practice, where the pharmacist works with a medical practitioner who acts as a supervisor. Mrs McDonald has already started this part of her training. “I have been sitting in on consultations with the GP and have been learning to take blood pressure measurements,” she explains. Dr Elfellah plans to start his period of learning in practice after the residential course. “I thought it would be clearer after the course what had to be done in the 12 days,” he says.

Dr Stewart explains: “We do not specify what the student has to do during the period of learning in practice: it is up to the student and medical practitioner to come up with a plan to meet the required competencies.” Pharmacists have to complete the equivalent of 12 whole days of practice but they do not have to be done at once. Mrs McDonald, for example, has completed several four-hour sessions.

Patients have been positive about Mrs McDonald’s new role. “The patients have been fine about me being present during the consultations despite the fact that they have had a wide variety of presenting complaints. None was surprised that a pharmacist was there: this shows the change in perception that pharmacists are now considered part of the primary care team,” she comments. “The doctor said to some of the patients that I would be giving consultations in the future and their reaction was ‘that’s fine’.”

Is it easy to balance the course with work and other commitments? Both Dr Elfellah and Mrs McDonald admit that it is hard but that it will only be for a short time.

Some pharmacists might choose to develop their skills further. Dr Scott Cunningham, postgraduate programmes leader, points out that credits earned in the supplementary prescribing course can count towards the postgraduate certificate in prescribing sciences.

All the pharmacists on the course at Robert Gordon University had to prove that there was a clinical need for them to become supplementary prescribers. But what do they think the future will hold for pharmacists?

Mrs McDonald sees a role for pharmacists managing chronic diseases “that doctors just don’t have time to do”. She hopes to have a clinic within each of the surgeries she currently works in. This could be open to 35,000 patients across the four practices. “If pharmacists want to feel integrated in primary care then supplementary prescribing is something that is inevitable. It will improve patient outcomes,” she says.

Dr Stewart comments: “One of the consultants at the local hospital told me that he has problems getting medical staff to run a heart failure outpatient clinic. This is an obvious area for supplementary prescribing: if the patient is given a clinical management plan on discharge then a supplementary prescriber can ensure its implementation at the follow-up outpatient clinics.”

Dr Elfellah hopes that supplementary prescribing will be a step towards independent prescribing for pharmacists. “Once the patient is diagnosed as having a condition then we don’t need the doctor to prescribe. It should be the pharmacist’s job,” he says. “Every pharmacist should be a supplementary prescriber.”


  * PDF files on PJ Online require Acrobat Reader 4 or later

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal